Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality of life, disease activity and preferences for administration routes in rheumatoid arthritis: a multicentre, prospective, observational study.
Direskeneli H, Karadag O, Ates A, Tufan A, Inanc N, Koca SS, Cetin GY, Akar S, Cinar M, Yilmaz S, Yilmaz N, Dalkilic E, Bes C, Yilmazer B, Sahin A, Ersözlü D, Tezcan ME, Sen N, Keser G, Kalyoncu U, Armagan B, Hacibedel B, Helvacioglu K, Cesur TY, Basibuyuk CS, Alkan S, Gunay LM. Direskeneli H, et al. Among authors: ersozlu d. Rheumatol Adv Pract. 2022 Sep 2;6(3):rkac071. doi: 10.1093/rap/rkac071. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 36133962 Free PMC article.
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data.
Kimyon G, Kalyoncu U, Kiraz S, Bes C, Coşkun N, Yağiz B, Küçükşahin O, Kanitez N, Erden A, Kiliç L, Bilgin E, Kaşifoğlu T, Emmungil H, Koca SS, Akar S, Çinar M, Yazisiz V, Ateş A, Ersözlü D, Gönüllü E, Mercan R, Ertenli İ. Kimyon G, et al. Among authors: ersozlu d. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):852-858. doi: 10.55563/clinexprheumatol/jhpymv. Epub 2020 Sep 4. Clin Exp Rheumatol. 2021. PMID: 32896266
In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
Yagiz B, Coskun BN, Pehlivan Y, Dalkilic E, Kiraz S, Yazisiz V, Kucuksahin O, Erden A, Kanitez NA, Kimyon G, Emmungil H, Bilge SY, Kasifoglu T, Bes C, Bolek EC, Bilgin E, Karatas A, Kelesoglu B, Ersozlu D, Gonullu EO, Mercan R, Yilmaz S, Karadag O, Akar S, Ertenli I, Kalyoncu U. Yagiz B, et al. Among authors: ersozlu d. Rheumatol Int. 2021 Nov;41(11):1915-1924. doi: 10.1007/s00296-021-04939-8. Epub 2021 Jul 5. Rheumatol Int. 2021. PMID: 34226947
Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic.
Kalyoncu U, Pehlivan Y, Akar S, Kaşifoğlu T, Kimyon G, Karadağ Ö, Dalkılıç HE, Ertenli Aİ, Kılıç L, Ersözlü D, Bes C, Emmungil H, Mercan R, Ediboğlu ED, Kanıtez N, Bilgin E, Çolak S, Koca SS, Gönüllü E, Küçükşahin O, Coşkun N, Yağız B, Kiraz S. Kalyoncu U, et al. Among authors: ersozlu d. Turk J Med Sci. 2021 Aug 30;51(4):1615-1623. doi: 10.3906/sag-2012-5. Turk J Med Sci. 2021. PMID: 33611869 Free PMC article.
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
İlgen U, Karadağ Ö, Emmungil H, Küçükşahin O, Koca SS, Erden A, Bes C, Alpay Kanıtez N, Dalkılıç E, Akar S, Mercan R, Çınar M, Kaşifoğlu T, Gönüllü E, Kimyon G, Ersözlü D, Atagündüz P, Kılıç L, Ertenli İ, Yazısız V, Ateş A, Kiraz S, Kalyoncu U. İlgen U, et al. Among authors: ersozlu d. Rheumatol Int. 2022 Oct;42(10):1797-1806. doi: 10.1007/s00296-022-05134-z. Epub 2022 Apr 29. Rheumatol Int. 2022. PMID: 35486197
Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?
Atagündüz P, Kiraz S, Akar S, Küçükşahin O, Erden A, Aksoy A, Coşkun BN, Yağiz B, Bes C, Alpay Kanitez N, Kilic L, Karadağ Ö, Kaşifoğlu T, Emmungil H, Cinar M, Kimyon G, Yazisiz V, Ateş A, Ersözlü D, Gönüllü E, Mercan R, Ertenli İ, Kalyoncu U. Atagündüz P, et al. Among authors: ersozlu d. Clin Exp Rheumatol. 2023 Mar;41(3):620-627. doi: 10.55563/clinexprheumatol/eb1zpo. Epub 2022 Jun 28. Clin Exp Rheumatol. 2023. PMID: 35766019 Free article.
Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results.
Yaşar Bilge NŞ, Kalyoncu U, Atagündüz P, Dalkılıç E, Pehlivan Y, Küçükşahin O, Bes C, Akar S, Cinar M, Emmungil H, Ersözlü D, Ateş A, Mercan R, Kimyon G, Koca SS, Gonullu E, Yazisiz V, Tekgöz E, Alpay-Kanitez N, Erden A, Kiraz S, Coskun BN, Yağız B, İlgen U, Karadağ Ö, Kilic L, Ertenli İ, Kasifoglu T. Yaşar Bilge NŞ, et al. Among authors: ersozlu d. Am J Ophthalmol. 2021 Aug;228:58-64. doi: 10.1016/j.ajo.2021.03.026. Epub 2021 Apr 4. Am J Ophthalmol. 2021. PMID: 33826929
Pregnancy in Takayasu's arteritis has a high risk of hypertension-related fetomaternal complications: A retrospective study of a Turkish cohort.
Gönenli MG, Kaymaz Tahra S, Kara M, Keser G, Yazıcı A, Erden A, Omma A, Gerçik Ö, Akar S, Aksu K, Kenar G, Kocaer SB, Önen F, Ersözlü D, Alibaz-Öner F, Bayramlar OF, Direskeneli H, Alpay-Kanıtez N. Gönenli MG, et al. Among authors: ersozlu d. Int J Rheum Dis. 2022 Feb;25(2):140-146. doi: 10.1111/1756-185X.14247. Epub 2021 Nov 17. Int J Rheum Dis. 2022. PMID: 34791826
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database.
Alpay Kanıtez N, Kiraz S, Dalkılıç E, Kimyon G, Mercan R, Karadağ Ö, Bes C, Kılıç L, Akar S, Ateş A, Emmungil H, Ertenli İ, Pehlivan Y, Coşkun BN, Yağız B, Ersözlü D, Gönüllü E, Çınar M, Kaşifoğlu T, Koca SS, Karasu U, Küçükşahin O, Kalyoncu U. Alpay Kanıtez N, et al. Among authors: ersozlu d. Eur J Rheumatol. 2022 Oct;9(4):206-211. doi: 10.5152/eurjrheum.2022.21153. Eur J Rheumatol. 2022. PMID: 36650959 Free PMC article.